Patents by Inventor Chad Koonce

Chad Koonce has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230078230
    Abstract: Provided herein are methods for the differentiation of pluripotent stem cells to committed cardiac progenitor cells. Further provided herein are methods for the use of the committed cardiac progenitor cells in the treatment of cardiac disorders.
    Type: Application
    Filed: September 13, 2022
    Publication date: March 16, 2023
    Applicant: FUJIFILM Cellular Dynamics, Inc.
    Inventors: Steven KATTMAN, Chad KOONCE, Meghan BOYER, Kristin STACK, Ellen HEBRON
  • Patent number: 9034584
    Abstract: The present invention concerns methods and compositions for promoting a conversion in stem cells or cells derived therefrom from glycolysis to aerobic respiration and its associated pathways, including oxidative phosphorylation, the TCA cycle, fatty acid oxidation, and pyruvate decarboxylation, for example. In specific embodiments, certain media is employed to improve metabolic maturation of particular stem cell-derived cells, including human embryonic stem cells and human induced pluripotent stem cells, for example. Particular media comprises media without glucose or optionally without pyruvate, with fatty acids, with L-carnitine, with taurine, creatine, non-essential amino acids, L-glutamine, and with anti-oxidants or free-radical scavengers, for example.
    Type: Grant
    Filed: July 27, 2012
    Date of Patent: May 19, 2015
    Assignee: Cellular Dynamics International, Inc.
    Inventors: Steven Kattman, Chad Koonce, Natsuyo Aoyama, Jennifer Luebke-Wheeler, Brad Swanson
  • Publication number: 20130029368
    Abstract: The present invention concerns methods and compositions for promoting a conversion in stem cells or cells derived therefrom from glycolysis to aerobic respiration and its associated pathways, including oxidative phosphorylation, the TCA cycle, fatty acid oxidation, and pyruvate decarboxylation, for example. In specific embodiments, certain media is employed to improve metabolic maturation of particular stem cell-derived cells, including human embryonic stem cells and human induced pluripotent stem cells, for example. Particular media comprises media without glucose or optionally without pyruvate, with fatty acids, with L-carnitine, with taurine, creatine, non-essential amino acids, L-glutamine, and with anti-oxidants or free-radical scavengers, for example.
    Type: Application
    Filed: July 27, 2012
    Publication date: January 31, 2013
    Inventors: Steven Kattman, Chad Koonce, Natsuyo Aoyama, Jennifer Luebke-Wheeler, Brad Swanson
  • Patent number: D1101100
    Type: Grant
    Filed: June 17, 2024
    Date of Patent: November 4, 2025
    Assignee: CUSTOM KRUISER LURES LLC
    Inventor: Chad Koonce